dc.contributor.author
Giner, Jacobo
dc.contributor.author
Villanueva-Saz, Sergio
dc.contributor.author
Alcover Amengual, Maria Magdalena
dc.contributor.author
Riera Lizandra, Ma. Cristina
dc.contributor.author
Fisa Saladrigas, Roser
dc.contributor.author
Verde, María Teresa
dc.contributor.author
Fernández, Antonio
dc.contributor.author
Yzuel, Andrés
dc.date.issued
2021-07-15T10:46:09Z
dc.date.issued
2022-07-31T05:10:22Z
dc.date.issued
2021-07-15T10:46:09Z
dc.identifier
https://hdl.handle.net/2445/179102
dc.description.abstract
The published information on the treatment of mustelid leishmaniosis is extremely scarce because there are only two case reports available. In one case, a domestic ferret (Mustela putorius furo) was treated with a combination of meglumine antimoniate plus allopurinol and, in the other case, a therapeutic regimen with allopurinol was administrated to a Eurasian otter (Lutra lutra). This article describes for the first time a combined therapeutic protocol with miltefosine (2 mg/kg once a day during 28 days per os), and allopurinol (10 mg/kg twice a day PO sine die) in a domestic ferret with splenomegaly, lymphadenomegaly and a facial pyogranulomatous dermatitis, with a moderate level of antibodies to Leishmania infantum.
dc.format
application/pdf
dc.publisher
Elsevier B.V.
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.vprsr.2021.100607
dc.relation
Verterinary Parasitology: Regional Studies and Reports, 2021
dc.relation
https://doi.org/10.1016/j.vprsr.2021.100607
dc.rights
cc-by-nc-nd (c) Elsevier B.V., 2021
dc.rights
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Biologia, Sanitat i Medi Ambient)
dc.subject
Malalties infeccioses en els animals
dc.subject
Parasitologia veterinària
dc.subject
Communicable diseases in animals
dc.subject
Veterinary parasitology
dc.title
Clinical leishmaniosis in a domestic ferret (Mustela putorius furo) treated with miltefosine plus allopurinol: Serological and clinical follow-up
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion